What QTc interval duration is considered prolonged in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prolonged QTc in Women

A QTc interval of ≥460 ms is considered prolonged in women according to the most authoritative AHA/ACCF/HRS guidelines. 1

Clinical Thresholds for Women

The 2009 AHA/ACCF/HRS scientific statement establishes 460 ms or longer as the threshold for prolonged QTc in women 1. This represents a practical clinical compromise based on large community-based populations using appropriate linear regression functions for QT-rate adjustment.

Risk Stratification by Severity

Beyond the basic threshold, you need to recognize escalating risk levels:

  • ≥460 ms: Prolonged QTc (abnormal) 1
  • >480 ms: Upper limit of normal (99th percentile) 2
  • >500 ms: Dangerous threshold associated with high risk of Torsade de Pointes (TdP) 2

A QTc >500 ms in either sex is considered dangerous and warrants immediate intervention, regardless of gender 2. This threshold is critical because it represents a major independent risk factor for TdP and requires removal of offending agents, correction of electrolyte abnormalities, and consideration of intravenous magnesium.

Age-Specific Considerations

The gender difference in QTc is not static across the lifespan. The QTc difference between men and women emerges during adolescence (when testosterone shortens QT in males) and becomes smaller after age 40, practically disappearing in older adults 1. More recent research suggests age-adjusted criteria may be more appropriate:

  • Age <40 years: 440 ms for women 3
  • Age 40-69 years: 450 ms for women 3
  • Age ≥70 years: 460 ms for women 3

However, the 2009 AHA/ACCF/HRS guideline recommendation of 460 ms remains the standard clinical threshold across all adult ages 1.

Important Clinical Caveats

Women are inherently at higher risk for drug-induced TdP compared to men, making accurate QTc assessment particularly critical 2. Female sex is consistently identified as an independent risk factor for TdP in hospitalized patients.

Common Pitfalls to Avoid:

  • Bazett's formula (QTcB) overcorrects at high heart rates, potentially leading to false-positive prolongations 1. Consider using Fridericia's formula or other correction methods when heart rate is elevated.

  • QRS prolongation artificially lengthens QT. In bundle branch blocks or ventricular conduction delays, use the JT interval (QT minus QRS duration) with JT-specific normal standards 1.

  • Don't ignore borderline values in high-risk contexts. Even a QTc increase of ≥60 ms from baseline after starting a QT-prolonging drug warrants concern 2.

ECG Warning Signs Beyond Absolute QTc Duration:

Watch for these harbingers of imminent TdP even if QTc is <500 ms:

  • T-U wave distortion that worsens after pauses
  • Macroscopic T-wave alternans
  • New ventricular ectopy or couplets
  • Short-long-short R-R cycle sequences 2

Practical Application

When evaluating a woman's ECG, use 460 ms as your action threshold for considering the QTc prolonged 1. If the QTc exceeds 500 ms, treat this as a medical urgency requiring immediate risk mitigation 2. Between 460-500 ms, carefully assess for additional risk factors (hypokalemia, hypomagnesemia, QT-prolonging drugs, heart disease) and monitor closely.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.